TGV-Biomed is dedicated to the development of AtbFinder. As a research-based and innovation-driven company, we devote our science to deepening the understanding of pathological processes and uncovering new approaches to the development of novel drugs. We believe that we can best achieve these goals together with partners who can supplement and complement our strengths and capabilities.
TGV-Biomed has successful partnerships involving companies, funds and academic institutions. Here are some examples of our partnerships.